다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

LGVN

Longeveron (LGVN)

Longeveron Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LGVN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/05	23:25	GlobeNewswire Inc.	Longeveron® to Present at the 37th Annual Roth Conference	NASDAQ:LGVN	Longeveron Inc
2025/03/01	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LGVN	Longeveron Inc
2025/03/01	06:04	GlobeNewswire Inc.	Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update	NASDAQ:LGVN	Longeveron Inc
2025/03/01	06:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:LGVN	Longeveron Inc
2025/02/21	22:30	GlobeNewswire Inc.	Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025	NASDAQ:LGVN	Longeveron Inc
2025/02/18	23:25	GlobeNewswire Inc.	Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™	NASDAQ:LGVN	Longeveron Inc
2025/01/31	06:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LGVN	Longeveron Inc
2025/01/07	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2025/01/07	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2025/01/07	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2025/01/07	09:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2024/12/18	23:10	GlobeNewswire Inc.	Longeveron to Present at Biotech Showcase 2025	NASDAQ:LGVN	Longeveron Inc
2024/11/13	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LGVN	Longeveron Inc
2024/11/13	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LGVN	Longeveron Inc
2024/11/13	06:05	GlobeNewswire Inc.	Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:LGVN	Longeveron Inc
2024/11/11	23:05	GlobeNewswire Inc.	Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)	NASDAQ:LGVN	Longeveron Inc
2024/11/05	06:05	GlobeNewswire Inc.	Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024	NASDAQ:LGVN	Longeveron Inc
2024/10/29	23:00	GlobeNewswire Inc.	Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)	NASDAQ:LGVN	Longeveron Inc
2024/10/28	04:10	GlobeNewswire Inc.	Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting	NASDAQ:LGVN	Longeveron Inc
2024/10/14	22:05	GlobeNewswire Inc.	Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)	NASDAQ:LGVN	Longeveron Inc
2024/10/09	22:05	GlobeNewswire Inc.	Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting	NASDAQ:LGVN	Longeveron Inc
2024/10/07	22:05	GlobeNewswire Inc.	Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day	NASDAQ:LGVN	Longeveron Inc
2024/10/04	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2024/10/04	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2024/10/04	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2024/10/04	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LGVN	Longeveron Inc
2024/10/02	22:05	GlobeNewswire Inc.	Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference	NASDAQ:LGVN	Longeveron Inc
2024/09/26	22:05	GlobeNewswire Inc.	Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa	NASDAQ:LGVN	Longeveron Inc
2024/09/03	22:00	GlobeNewswire Inc.	Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)	NASDAQ:LGVN	Longeveron Inc
2024/08/27	05:05	GlobeNewswire Inc.	Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:LGVN	Longeveron Inc

검색 관련기사 보기:NASDAQ:LGVN

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

Energy Select Sector SPDR

US Dollar vs Euro

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관